Barnett & Company’s Medtronic MDT Stock Holding History

Barnett & Company’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-296	Closed	-$37K	–	229
2021 Q2	$37K	Hold	296	–	–	0.02%	156
2021 Q1	$35K	Hold	296	–	–	0.02%	180
2020 Q4	$34K	Hold	296	–	–	0.02%	180
2020 Q3	$31K	Hold	296	–	–	0.02%	178
2020 Q2	$27K	Hold	296	–	–	0.02%	166
2020 Q1	$27K	Hold	296	–	–	0.03%	169
2019 Q4	$34K	Buy	+296	New	+$32.5K	0.02%	197
2019 Q2	–	Sell	-300	Closed	-$27K	–	302
2019 Q1	$27K	Hold	300	–	–	0.02%	205
2018 Q4	$27K	Hold	300	–	–	0.02%	214
2018 Q3	$30K	Hold	300	–	–	0.01%	228
2018 Q2	$26K	Hold	300	–	–	0.01%	211
2018 Q1	$24K	Hold	300	–	–	0.01%	223
2017 Q4	$24K	Hold	300	–	–	0.01%	235
2017 Q3	$23K	Hold	300	–	–	0.01%	232
2017 Q2	$27K	Hold	300	–	–	0.01%	242
2017 Q1	$24K	Hold	300	–	–	0.01%	232
2016 Q4	$21K	Hold	300	–	–	0.01%	268
2016 Q3	$26K	Buy	300 +65	+28%	+$5.66K	0.01%	258
2016 Q2	$20K	Hold	235	–	–	0.01%	271
2016 Q1	$18K	Buy	+235	New	+$17.7K	0.01%	288

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.14B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barnett & Company's MDT Position: Q3 2021 in Review

Barnett & Company sold out of Medtronic (MDT) in Q3 2021, closing a stake of 296 shares — an estimated $37K sold.

Barnett & Company first reported a position in MDT in Q1 2016 and held it in 20 quarters. The position peaked at $37K in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Barnett & Company reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
Barnett & Company sold 296 Medtronic shares in Q3 2021, an estimated $37K.
Barnett & Company first reported a position in Medtronic in Q1 2016 and held it in 20 quarters.
Barnett & Company's Medtronic position peaked at $37K in Q2 2021.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Barnett & Company's 13F filing for Q3 2021, filed 4 Nov 2021.